Michael A. Archer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Michael A. Archer has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Jessica G. Y. Luc
Division of Cardiovascular Surgery, Department of Surgery, University of British Columbia, Vancouver, BC, Canada
2 shared publications Raphael Bueno
The Thoracic Surgery Oncology laboratory and the International Mesothelioma Program, Division of Thoracic Surgery and the Lung Center, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts
2 shared publicationsYifan Zheng
The Thoracic Surgery Oncology laboratory and the International Mesothelioma Program, Division of Thoracic Surgery and the Lung Center, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts
2 shared publicationsAlexander G. Holman
Center for Cancer Computational Biology, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Harvard School of Public Health, Boston, Massachusetts
1 shared publicationAlexander S. Gutin
Myriad Genetics, Inc., Salt Lake City, UT
1 shared publication- Anne-Renee Hartman
Myriad Genetics, Inc., Salt Lake City, UT
1 shared publication
Latest Publications
- 1 February 2020
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 109 (2) , 589-595
Social Media Improves Cardiothoracic Surgery Literature Dissemination: Results of a Randomized Trial
- 1 February 2020
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 109 (2) , 589-595
Social Media Improves Cardiothoracic Surgery Literature Dissemination: Results of a Randomized Trial
- 1 January 2020
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 109 (1) , 285-290
Trainee Thoracic Surgery Social Media Network: Early Experience With TweetChat-Based Journal Clubs
- 1 January 2020
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 109 (1) , 285-290
Trainee Thoracic Surgery Social Media Network: Early Experience With TweetChat-Based Journal Clubs
- 1 November 2017
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 104 (5) , e359-e361
Novel Airway and Ventilator Management of Tracheobronchial Disruption After Blunt Trauma
- 1 November 2017
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 104 (5) , e359-e361
Novel Airway and Ventilator Management of Tracheobronchial Disruption After Blunt Trauma
- 14 January 2016
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 76 (2) , 319-328
Gender-Specific Molecular and Clinical Features Underlie Malignant Pleural Mesothelioma
Malignant pleural mesothelioma (MPM) is an aggressive cancer that occurs more frequently in men, but is associated with longer survival in women. Insight into the survival advantage of female patients may advance the molecular understanding of MPM and identify therapeutic interventions that will improve the prognosis for all MPM patients. In this study, we performed whole-genome sequencing of tumor specimens from 10 MPM patients and matched control samples to identify potential driver mutations underlying MPM. We identified molecular differences associated with gender and histology. Specifically, single-nucleotide variants of BAP1 were observed in 21% of cases, with lower mutation rates observed in sarcomatoid MPM (P < 0.001). Chromosome 22q loss was more frequently associated with the epithelioid than that nonepitheliod histology (P = 0.037), whereas CDKN2A deletions occurred more frequently in nonepithelioid subtypes among men (P = 0.021) and were correlated with shorter overall survival for the entire cohort (P = 0.002) and for men (P = 0.012). Furthermore, women were more likely to harbor TP53 mutations (P = 0.004). Novel mutations were found in genes associated with the integrin-linked kinase pathway, including MYH9 and RHOA. Moreover, expression levels of BAP1, MYH9, and RHOA were significantly higher in nonepithelioid tumors, and were associated with significant reduction in survival of the entire cohort and across gender subgroups. Collectively, our findings indicate that diverse mechanisms highly related to gender and histology appear to drive MPM. Cancer Res; 76(2); 319–28. ©2015 AACR.
- 14 January 2016
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 76 (2) , 319-328
Gender-Specific Molecular and Clinical Features Underlie Malignant Pleural Mesothelioma
Malignant pleural mesothelioma (MPM) is an aggressive cancer that occurs more frequently in men, but is associated with longer survival in women. Insight into the survival advantage of female patients may advance the molecular understanding of MPM and identify therapeutic interventions that will improve the prognosis for all MPM patients. In this study, we performed whole-genome sequencing of tumor specimens from 10 MPM patients and matched control samples to identify potential driver mutations underlying MPM. We identified molecular differences associated with gender and histology. Specifically, single-nucleotide variants of BAP1 were observed in 21% of cases, with lower mutation rates observed in sarcomatoid MPM (P < 0.001). Chromosome 22q loss was more frequently associated with the epithelioid than that nonepitheliod histology (P = 0.037), whereas CDKN2A deletions occurred more frequently in nonepithelioid subtypes among men (P = 0.021) and were correlated with shorter overall survival for the entire cohort (P = 0.002) and for men (P = 0.012). Furthermore, women were more likely to harbor TP53 mutations (P = 0.004). Novel mutations were found in genes associated with the integrin-linked kinase pathway, including MYH9 and RHOA. Moreover, expression levels of BAP1, MYH9, and RHOA were significantly higher in nonepithelioid tumors, and were associated with significant reduction in survival of the entire cohort and across gender subgroups. Collectively, our findings indicate that diverse mechanisms highly related to gender and histology appear to drive MPM. Cancer Res; 76(2); 319–28. ©2015 AACR.
- Open Access
- 1 January 2015
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 10 (1) , 67-73
Validation of a Molecular and Pathological Model for Five-Year Mortality Risk in Patients with Early Stage Lung Adenocarcinoma
- 1 January 2015
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 10 (1) , 67-73
Open AccessValidation of a Molecular and Pathological Model for Five-Year Mortality Risk in Patients with Early Stage Lung Adenocarcinoma